Virtual Reality for Pain and Well-Being in Older Adults
RecruitingNot applicableNCT07607899
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
Chronic pain is common among adults aged 65 and older and can reduce mobility, independence, mood, and quality of life. Many older adults also develop a fear of movement because they worry that physical activity will increase their pain or cause injury. This fear can lead to reduced activity, physical deconditioning, and further loss of independence. This study aims to evaluate the feasibility, acceptability, and potential impact of Moving Without Fear or Pain, a program using immersive virtual reality rehabilitation to gradually reintroduce movement in a safe and engaging way. The virtual reality intervention includes up to eight individualized sessions over approximately one month. Sessions last 5 to 30 minutes and are supervised by a trained clinician. Participants wear a virtual reality headset and are immersed in calming or engaging environments, such as nature settings. Depending on their comfort and abilities, sessions may begin with passive guided motor imagery and progress to active movement within interactive virtual environments. Some applications allow participants to control movement in the virtual world through gentle physical activity, such as stepping or upper-body movement. The intervention is personalized to each participant's physical capacity, preferences, and rehabilitation goals. The aim is to reduce fear of movement, increase confidence, and promote safe re-engagement in physical activity. In this pilot randomized controlled trial, 24 older adults with chronic pain will be randomly assigned to one of two groups: 1) Experimental Group: Participants will receive care, and up to eight immersive virtual reality rehabilitation sessions. 2) Control Group: Participants will receive usual care, without virtual reality sessions. The findings will inform a larger future study.
Study details
- Official title
- Moving Without Fear or Pain: Use of Immersive Virtual Reality to Reduce Pain and Improve Well-Being in Older Adults
- Conditions
- Chronic Pain
- Kinesiophobia (Fear of Movement)
- Interventions
- Device: Virtual Reality-Supported Rehabilitation
- Other: Usual Care
- Sponsor
- Laval University
- Collaborators
- McGill University; École de technologie supérieure; Université du Québec à Chicoutimi; Université de Sherbrooke
- Start date
- 2026-09-14
- Primary completion
- 2027-03
- Sex
- All
- Age range
- from 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age 65 years or older * Able to understand and communicate in French * Chronic pain lasting 6 months or longer * Average pain intensity of 3 or greater on a 0-10 Numeric Rating Scale during the week prior to enrollment * Score greater than 25 on the 11-item Tampa Scale of Kinesiophobia (TSK-11) * No neurocognitive impairment (Mini-Mental State Examination \[MMSE\] ≥ 24), or mild neurocognitive impairment (MMSE 18-24) with preserved capacity to consent (University of California Brief Assessment of Capacity to Consent \[UBACC\] score ≥ 12) * Normal or corrected-to-normal visual acuity Exclusion Criteria: * Severe motion sickness or intolerance that would prevent safe use of a virtual reality headset (experimental group only) * Medical condition that would prevent safe participation in rehabilitation activities * Presence of open wounds or infection at painful or contralateral sites
Canadian sites (2)
| Facility | City | Province |
|---|---|---|
| CIUSSS de la Capitale-Nationale | Québec | Quebec |
| CISSS de Chaudière-Appalaches | Sainte-Marie | Quebec |
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07607899